We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Recombinant Lysozyme Derived From Plants

By Biotechdaily staff writers
Posted on 13 Mar 2006
A recombinant human lysozyme has been produced in an animal-free system. More...
The bacterial-cell lysis agent can be used in diagnostic applications, bioprocessing, and life science research.

The lysozyme has many advantages over other lysing agents. Because it is produced in an animal-free system, it is free of infectious viral or prion contaminants. Prions are the causative agent of bovine spongiform encephalopathy (BSE), or mad cow disease. The lysozyme outperforms chicken lysozyme, a common animal-derived cell lysis agent, and is four times more active per mg for lysing Micrococcus and E coli. Lysobac, the lysozyme produced by Ventria Bioscience (Sacramento, CA, USA), is available in packages of 100 million, 10 billion, and 100 billion.

Lysobac is a recombinant protein that provides consistent cell lysis results so that process changes are minimized. For bioprocessing applications, it saves time by eliminating steps in the production process because it enables in-culture protein extraction. In addition, Lysobac is highly active and therefore it adds minimal volume to the final extract. It is cheaper than chicken lysozyme because of its high activity and efficient production methods. Lysobac is a gentle lysing agent providing minimal risk of denaturing the protein product.



Related Links:
Ventria

Gold Member
Troponin T QC
Troponin T Quality Control
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Respiratory Syncytial Virus Test
OSOM® RSV Test
New
Glucose Tolerance Test
NERL Trutol
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The OnePCR system has received US FDA 510(k) clearance (Photo courtesy of Genes2Me)

Fully Automated Detection System Revolutionizes Point-Of-Care Testing

A state-of-the-art, fully automated system simplifies diagnostics by integrating nucleic acid extraction and real-time PCR (RT-PCR) detection into a single, streamlined process. Its user-friendly design,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Microbiology

view channel
Image: The U.S. FDA-cleared IntelliSep rapid host response diagnostic represents a breakthrough in sepsis care (Photo courtesy of Cytovale)

Rapid Diagnostic Test Slashes Sepsis Mortality by 39%

Sepsis remains one of the most challenging and fatal conditions in contemporary healthcare, accounting for nearly one-third of all hospital-related deaths in the United States. In emergency departments... Read more

Industry

view channel
Image: The knowledge transfer partnership will further develop technology to rapidly diagnose serious and high-risk infectious diseases (Photo courtesy of Aston University)

Aston University and BG Research Partner to Commercialize Groundbreaking Medical Diagnostic

Technology that can rapidly diagnose high-consequence infectious diseases will take a major step forward towards commercialization, thanks to a new partnership. A Knowledge Transfer Partnership (KTP)... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.